AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,300.00
+450.00 (11.69%)
At close: Nov 6, 2026

AriBioLab Revenue

AriBioLab had revenue of 173.16M KRW in the twelve months ending June 30, 2026, up 9.17% year-over-year. In the year 2025, AriBioLab had annual revenue of 158.62M, down -57.21%. That makes AriBioLab the 45,872nd largest company in the world by revenue and 2,609th in South Korea.

Revenue (ttm)
173.16M
Revenue Growth
+9.17%
P/S Ratio
695.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
120.46B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025158.62M-212.04M-57.21%
Dec 31, 2024370.66M76.53M26.02%
Dec 31, 2023294.12M114.64M63.87%
Dec 31, 2022179.48M-320.52M-64.10%
Dec 31, 2021500.00M422.20M542.70%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cell Biotech60.40B
ISU Abxis51.04B
Choong Ang Vaccine Laboratory39.19B
Prestige Biologics26.67B
BIO-FD&C19.53B
Bio Solution17.39B
TiumBio15.00B
Y-Biologics3.17B
Revenue Rankings